Related Experiment Video
Updated: Mar 24, 2026
09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.2K
Artificial intelligence-guided nanoparticle design for advanced targeted drug delivery
1Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Bioimpacts : BI
|February 20, 2026
Summary
Artificial intelligence (AI) can precisely predict nanoparticle (NP) design for targeted therapy, improving drug delivery and optimizing outcomes. Integrating AI in nanomedicine accelerates clinical trials and enhances personalized treatments.
Area of Science:
- Pharmaceutical nanotechnology
- Medical nanotechnology
- Drug delivery systems
Background:
- Nanoparticles (NPs) are crucial for targeted therapy, but precise control over their properties (size, zeta potential, surface modification) is challenging.
- Traditional trial-and-error methods for NP development are time-consuming and less efficient than smart tool-based approaches.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
91
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
91
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
106
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
106